Reimagining the infrastructure of cancer care

Transforming possibilities into results
Featured products & solutions
Clinicians, researchers, and regulators rely on FLATIRON HEALTH® technology and evidence to learn faster and power smarter care for every patient.
Achieve your oncology real-world evidence goals faster and more efficiently
Generate robust evidence and insights by partnering with Flatiron's expert team of clinicians, scientists, and health data analysts.
See how— Hear from our customers
Fit-for-purpose RWE solutions
Flatiron was chosen because it's fit for purpose. You have the right population and good sample size with data for the endpoint, which is overall response rate. A key learning is you need to choose a database with good quality.
— By the numbers
5 million+
5 million+ patient records de-identified and available for research
Unleash precision oncology with our customizable clinical decision support platform
Improve the patient experience, streamline operations, and increase revenue with instinctive workflows, up-to-date treatment guidelines, and actionable data.
See how— Hear from our customers
Expand insights at the point of care
Flatiron Assist is a decision support tool that helps us choose and find the right regimens for our patients, stay within NCCN guidelines, and the treatment plans are very robust and customizable.
— By the numbers
44% reduction
44% reduction in the number of unique regimens ordered across cancer centers using Flatiron Assist™
























New and noteworthy
featured news and insights
Explore the latest insights, research, and stories from Flatiron's global team.
- Read more

The real-world perspective: Why global RWE matters in modern oncology
In my work as a clinician, I've spent nearly two decades watching the same pattern repeat itself: the treatments that earn approval through randomised controlled trials, our gold standard for evidence, are often tested on populations that don't look like the patients sitting in my clinic. The gap between what clinical trials demonstrate and what I observe in clinical practice isn't merely theoretical—it's reflected in patients sitting in our clinics—and this is precisely where real-world evidence becomes not just valuable but essential.
- Read more

Flatiron Health and Community Oncology Alliance partner to deliver first comprehensive, real-world assessment of care in community oncology
STUDY: Cancer patients experience longer survival in community oncology settings, affirming the high-quality care delivered across community practices
- Read more

High-quality, validated AI-enabled research: Insights from recent prostate cancer research
If there’s a question I hear most often from researchers it’s: How can we trust real-world data extracted by AI?
- Read more

Flatiron Health announces 18 research acceptances featuring the company's real-world data to be presented at ISPOR 2026
New research showcases the impact of large language models from extracting nuanced clinical information from unstructured data sources to successfully building digital twin models that simulate patient outcomes under different treatment scenarios